Completado

Utility of Isoproterenol Challenge Test to Detect Disease in Patients With Incomplete Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy

0 criterios cumplidosConsulta de un vistazo cómo tu perfil cumple con cada criterio de elegibilidad.
Qué se está recopilando

Colección de datos

Quiénes están siendo reclutados

Enfermedades Cardiovasculares+2

+ Anomalías Congénitas

+ Defectos del corazón congénitos

Ver todos los criterios de elegibilidad
Cómo está diseñado el estudio

Observacional
Inicio del estudio: mayo de 2004
Ver detalles del protocolo

Resumen

Patrocinador PrincipalNational Institutes of Health Clinical Center (CC)
Última actualización: 18 de enero de 2026
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Fecha de inicio: 1 de mayo de 2004

Fecha en la que se inscribió al primer participante.

Arrhythmogenic right ventricular cardiomyopathy (ARVC) formerly referred to as arrhythmogenic right ventricular dysplasia (ARVD) is a familial hetergenous clinical and molecular disease characterized by dilatation and dysfunction of the right ventricle and ventricular arrhythmias. The ventricular arrhythmias are heart rate and catecholamine dependent. Not infrequently, there is involvement of the left ventricle. The diagnosis of ARVC is critical as therapy including implantable defibrillators may prevent sudden death. However, identification of affected family members remains a major challenge due to limitation of current imaging and diagnostic techniques. We propose (1) to establish the sensitivity and specificity of the isoproterenol challenge test for ARVC by testing both patients with known ARVC and healthy volunteers; (2) to estimate the proportion of family members who present with incomplete criteria for ARVC but are subsequently diagnosed with the condition by an isoproterenol challenge test; and, (3) to study the inheritance of ARVC and the potential role of occult infection in its development.

Título OficialUtility of Isoproterenol Challenge Test to Detect Disease in Patients With Incomplete Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy 
NCT00083395
Patrocinador PrincipalNational Institutes of Health Clinical Center (CC)
Última actualización: 18 de enero de 2026
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Protocolo

Esta sección proporciona detalles del plan del estudio, incluyendo cómo está diseñado y qué se está evaluando.
Detalles del Diseño

Se reclutarán 160 pacientes

Número total de participantes que el ensayo clínico espera reclutar.

Elegibilidad

Los investigadores buscan pacientes que cumplan ciertos criterios, conocidos como criterios de elegibilidad: estado general de salud o tratamientos previos.
Condiciones
Criterios

Cualquier sexo

Sexo biológico de los participantes elegibles para inscribirse.

Voluntarios sanos permitidos

Indica si personas sanas, sin la condición que se estudia, pueden participar.

Condiciones

Patología

Enfermedades CardiovascularesAnomalías CongénitasDefectos del corazón congénitosEnfermedades del CorazónCardiomiopatías

Criterios

INCLUSION CRITERIA: Patients with ARVC: Either gender, aged greater than 5 years. The presence of two major criteria; one major and two minor criteria; or four minor criteria from separate diagnostic categories. Normal Volunteers: Age and gender matched with ARVC patients, age greater than 18 years. No known cardiac disease. Normal EKG, normal echocardiogram, normal Bruce protocol treadmill exercise test. Family Members of Patients with ARVC: Either gender, aged greater than 5 years. A proband with ARVC EXCLUSION CRITERIA: Patients with ARVC: Pregnancy or lactation excludes tests with potential risk, e.g. radiation, isoprenaline, MRI, but does not exclude 12-lead ECG and echocardiogram. Coronary artery disease. Known infiltrate or congenital heart disease that could mimic the appearances of ARVC. Asthma prevents participation in Isoproterenol infusion. Any other condition that would prevent participation in the study. Normal Volunteers: Pregnancy or lactation. Asthma. Coronary artery disease, hypertension, diabetes, hypertrophic cardiomyopathy, or other known cardiomyopathy. Known infiltrative or congenital heart disease that could mimic the appearances of ARVC. Any Acute or chronic illness. Chronic drug therapy. Family Members of Patients with ARVC: Pregnancy or lactation excludes tests with potential risk, e.g. radiation, isoprenaline, MRI, but does not exclude 12-lead ECG and echocardiogram. Coronary artery disease. Known infiltrative or congenital heart disease that could mimic the appearances of ARVC. Asthma prevents participation in Isoproterenol infusion. Any other condition that would prevent participation in the study.

Centros del Estudio

Estos son los hospitales, clínicas o centros de investigación donde se lleva a cabo el estudio. Puedes encontrar la ubicación más cercana a ti y su estado de reclutamiento.

Este estudio tiene una ubicación

Suspendido

National Institutes of Health Clinical Center (CC)

Bethesda, United StatesVer ubicación
Completado1 Centros de Estudio